Body Surface Area

average value: 1.73 sq.m

Loading...

average value: 1.73 sq.m

References

  1. Denisa Muraru. How to conduct clinical research in cardiovascular imaging: a primer for clinical cardiologists and researchers-a statement of the European Association of Cardiovascular Imaging (EACVI) of the ESC.. European heart journal. Cardiovascular Imaging, 2024
  2. NA. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease.. Kidney international, 2024
  3. Eric M Isselbacher. 2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines.. Circulation, 2022
  4. Jennifer J Griggs. Appropriate Systemic Therapy Dosing for Obese Adult Patients With Cancer: ASCO Guideline Update.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2021
  5. G. Dhall. DDEL-02. DECREASED TOXICITY OF CONVENTIONAL DOSE CHEMOTHERAPY UTILIZING BODY WEIGHT INSTEAD OF BODY SURFACE AREA FOR DOSING IN YOUNG CHILDREN <6 YEARS OLD ENROLLED ON THE “HEAD START” 4 CLINICAL TRIAL. Neuro-Oncology, 2020
  6. G. Dhall. PHRM-05. INCREASED TOXICITY OF CONVENTIONAL DOSE CHEMOTHERAPY UTILIZING BODY SURFACE AREA FOR DOSING IN INFANTS AND YOUNG CHILDREN ENROLLED ON THE “HEAD START” 4 CLINICAL TRIAL. Neuro-Oncology, 2018
  7. L. Demer. Rigor and Reproducibility in Analysis of Vascular Calcification.. Circulation research, 2017
  8. A. Adler. Effects of body surface area-indexed calculations in the morbidly obese: a mathematical analysis.. Journal of cardiothoracic and vascular anesthesia, 2013
  9. Mirjam N Trame. Population Pharmacokinetics of Busulfan in Children: Increased Evidence for Body Surface Area and Allometric Body Weight Dosing of Busulfan in Children. Clinical Cancer Research, 2011
  10. F. E. Jongh. Body-surface area-based dosing does not increase accuracy of predicting cisplatin exposure.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001
  11. Reference - https://pubmed.ncbi.nlm.nih.gov/10914710/